AI-Driven Primary Care Clinical Assessment Platform for Allied Health Professionals (PC-CAP)

面向联合医疗专业人员的人工智能驱动的初级保健临床评估平台 (PC-CAP)

• 批准号: 10038273
• 金额: $ 33.21万
• 依托单位: DEM DX LIMITED
• 依托单位国家: 英国
• 项目类别: Collaborative R&D
• 财政年份: 2023
• 资助国家: 英国
• 起止时间: 2023 至 无数据
• 项目状态: 未结题
• 来源: https://gtr.ukri.org/projects?ref=10038273
• 关键词: AI; Driven; Primary; Care; Clinical

NHS Primary Care is in crisis: GP practices are experiencing sharply declining GP numbers (1,565 FTE fewer than 2015) and rising demand (6.1m waiting lists; 30.1m appointments in March 2022). They are struggling to recruit and retain staff (7,000 GP shortfall projected within 5 years). This impacts patient care.The NHS Long Term Plan aims to meet these challenges, allocating £4.5bn to expand the role of allied healthcare professionals (AHPs), giving more front-line clinical assessment and triage responsibilities to nurse associates, physician associates, clinical pharmacists and social prescribing link workers.This workforce redesign brings new challenges. AHPs are reporting feeling out-of-their-depth and often requiring senior guidance. This is resulting in inefficient, disrupted workflows, inconsistent patient delivery and delays in care, creating high levels of burnout (44% of AHPs reported job anxiety in 2020/21) and 20% turnover. AHPs have raised the urgent need for AHP-specific support tools, with existing systems not meeting their needs.This project will deliver DemDx's Primary Care Clinical Assessment Platform (PC-CAP): the only support tool designed specifically for and with AHPs. Innovations include:* Technical: AI allowing dynamic consideration of complex associations across 10,000s of symptoms, differentials and "red flags" in validated NICE CKS data. PC-CAP's data-driven (vs specialist-driven) approach will enable AHPs to make sense of complex data associations to make safe, consistent decisions. PC-CAP provides data weighting, enabling identification and prioritisation of most probable conditions, driving accuracy of recommendations. It links to local pathways/protocols to inform best referral options. All outputs are tailored to AHP competencies, and we initially focus on common minor illnesses. Proof-of-concept of the AI has been demonstrated at Moorfield's Eye Hospital.* Scientific: powered by datasets, including Oxford-RCGP dataset, covering 1800 general practices, NICE CKS, and PCN anonymised patient data.* Commercial: the only solution designed specifically for AHPs; fully interoperable system which can be licenced and integrated into clinical pathways worldwide..PC-CAP offers socio-economic impact by:* enabling AHPs to confidently, autonomously undertake appointments.* increasing GP capacity to focus on complex patients.* reducing waiting times, preventing escalation of conditions, enabling shorter treatment pathways, reducing hospital admissions; improving care and quality adjusted life years.* enabling £16.9m/year NHS savings: reduced operational (£6.8m), A&E visit (£5m), ambulance (£3.8m) and GP locum costs (£1m).Our serviceable addressable market is £160m UK and £2.3bn worldwide, with use cases in primary, community, urgent, emergency and secondary care.

NHS初级保健正处于危机之中：全科医生数量急剧下降（比2015年减少了1565名全职医生），需求不断上升（等待名单有610万人；2022年3月预约人数为3010万人）。他们正在努力招聘和留住员工（预计5年内短缺7000名GP）。这影响了病人的护理。NHS长期计划旨在应对这些挑战，拨款45亿英镑扩大联合医疗保健专业人员（ahp）的作用，将更多的一线临床评估和分诊责任赋予护士助理、医生助理、临床药剂师和社会处方联系工作者。这种劳动力的重新设计带来了新的挑战。ahp报告称，他们感到力不胜任，往往需要高层指导。这导致工作流程效率低下、中断、病人交付不一致和护理延误，造成高度倦怠（44%的ahp报告在2020/21年度工作焦虑）和20%的人员流失率。ahp提出了对ahp专用支持工具的迫切需求，现有的系统不能满足他们的需求。该项目将提供DemDx的初级保健临床评估平台（PC-CAP）：这是唯一专门为ahp设计的支持工具。*技术方面：人工智能允许在经过验证的NICE CKS数据中动态考虑10,000种症状、差异和“危险信号”之间的复杂关联。PC-CAP的数据驱动（相对于专家驱动）方法将使ahp能够理解复杂的数据关联，从而做出安全、一致的决策。PC-CAP提供数据加权，使识别和最可能的条件的优先级，驱动建议的准确性。它链接到当地途径/协议，以告知最佳转诊选择。所有产出都是针对AHP能力量身定制的，我们最初的重点是常见的小病。人工智能的概念验证已经在穆尔菲尔德眼科医院进行了演示。*科学：由数据集提供支持，包括牛津- rcgp数据集，涵盖1800个一般实践，NICE CKS和PCN匿名患者数据。*商业：唯一专门为ahp设计的解决方案；完全可互操作的系统，可以授权和整合到全球临床途径。PC-CAP提供社会经济影响：*使ahp能够自信，自主地承担任命。*提高全科医生关注复杂病人的能力。*缩短等待时间，防止病情升级，缩短治疗途径，减少住院人数；改善护理和质量调整生命年。*每年为NHS节省1690万英镑：减少运营费用（680万英镑）、急诊费用（500万英镑）、救护车费用（380万英镑）和GP现场费用（100万英镑）。我们可服务的目标市场是英国1.6亿英镑，全球23亿英镑，用例包括初级、社区、紧急、紧急和二级护理。